lpar1_human
NAME
4Z34
ORGANISM
Human (Homo sapiens)
PROTEIN NAME
lpar1_human
SOURCE
SWISSPROT
SEQUENCE
Perspective:
Wild-type
Construct
|
|||||||||
N-term | |||||||||
M
|
A
|
A
|
I
|
S
|
T
|
S
|
I
|
P
|
V
|
10 |
I
|
S
|
Q
|
P
|
Q
|
F
|
T
|
A
|
M
|
N
|
20 |
E
|
P
|
Q
|
C
|
F
|
Y
|
N
|
E
|
S
|
I
|
30 |
A
|
F
|
F
|
Y
|
N
|
R
|
S
|
G
|
K
|
H
|
40 |
TM1 | |||||||||
L
|
A
|
T
|
E
|
W
|
N
|
T
|
V
|
S
|
K
|
50 |
L
|
V
|
M
|
G
|
L
|
G
|
I
|
T
|
V
|
C
|
60 |
I
|
F
|
I
|
M
|
L
|
A
|
N
|
L
|
L
|
V
|
70 |
M
|
V
|
A
|
I
|
Y
|
V
|
N
|
R
|
R
|
F
|
80 |
ICL1 | TM2 | ||||||||
H
|
F
|
P
|
I
|
Y
|
Y
|
L
|
M
|
A
|
N
|
90 |
L
|
A
|
A
|
A
|
D
|
F
|
F
|
A
|
G
|
L
|
100 |
A
|
Y
|
F
|
Y
|
L
|
M
|
F
|
N
|
T
|
G
|
110 |
ECL1 | TM3 | ||||||||
P
|
N
|
T
|
R
|
R
|
L
|
T
|
V
|
S
|
T
|
120 |
W
|
L
|
L
|
R
|
Q
|
G
|
L
|
I
|
D
|
T
|
130 |
S
|
L
|
T
|
A
|
S
|
V
|
A
|
N
|
L
|
L
|
140 |
A
|
I
|
A
|
I
|
E
|
R
|
H
|
I
|
T
|
V
|
150 |
ICL2 | |||||||||
F
|
R
|
M
|
Q
|
L
|
H
|
T
|
R
|
M
|
S
|
160 |
TM4 | |||||||||
N
|
R
|
R
|
V
|
V
|
V
|
V
|
I
|
V
|
V
|
170 |
I
|
W
|
T
|
M
|
A
|
I
|
V
|
M
|
G
|
A
|
180 |
ECL2 | |||||||||
I
|
P
|
S
|
V
|
G
|
W
|
N
|
C
|
I
|
C
|
190 |
D
|
I
|
E
|
N
|
C
|
S
|
N
|
M
|
A
|
P
|
200 |
TM5 | |||||||||
L
|
Y
|
S
|
D
|
S
|
Y
|
L
|
V
|
F
|
W
|
210 |
A
|
I
|
F
|
N
|
L
|
V
|
T
|
F
|
V
|
V
|
220 |
M
|
V
|
V
|
L
|
Y
|
A
|
H
|
I
|
F
|
G
|
230 |
|
|
|
|
|
|
|
|
||
Y
|
V
|
R
|
Q
|
R
|
T
|
M
|
R
|
M
|
S
|
240 |
|
|
|
|
|
|
|
|||
ICL3 | TM6 | ||||||||
R
|
H
|
S
|
S
|
G
|
P
|
R
|
R
|
N
|
R
|
250 |
D
|
T
|
M
|
M
|
S
|
L
|
L
|
K
|
T
|
V
|
260 |
V
|
I
|
V
|
L
|
G
|
A
|
F
|
I
|
I
|
C
|
270 |
W
|
T
|
P
|
G
|
L
|
V
|
L
|
L
|
L
|
L
|
280 |
ECL3 | TM7 | |||||||||
D
|
V
|
C
|
C
|
P
|
Q
|
C
|
D
|
V
|
L
|
|
290 |
A
|
Y
|
E
|
K
|
F
|
F
|
L
|
L
|
L
|
A
|
300 |
E
|
F
|
N
|
S
|
A
|
M
|
N
|
P
|
I
|
I
|
310 |
H8 | |||||||||
Y
|
S
|
Y
|
R
|
D
|
K
|
E
|
M
|
S
|
A
|
320 |
|
|
|
|
||||||
T
|
F
|
R
|
Q
|
I
|
L
|
C
|
C
|
Q
|
R
|
330 |
|
|
|
|
|
|
|
|
|
|
C-term | |||||||||
S
|
E
|
N
|
P
|
T
|
G
|
P
|
T
|
E
|
G
|
340 |
|
|
|
|
|
|
|
|
|
|
S
|
D
|
R
|
S
|
A
|
S
|
S
|
L
|
N
|
H
|
350 |
|
|
|
|
|
|
|
|
|
|
T
|
I
|
L
|
A
|
G
|
V
|
H
|
S
|
N
|
D
|
360 |
|
|
|
|
H
|
S
|
V
|
V
|
|
|
|
|
|
|
|
|
|
|
|
hemagglutin | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
N-term | |||||||||
|
A
|
A
|
I
|
S
|
T
|
S
|
I
|
P
|
V
|
10 |
I
|
S
|
Q
|
P
|
Q
|
F
|
T
|
A
|
M
|
N
|
20 |
E
|
P
|
Q
|
C
|
F
|
Y
|
N
|
E
|
S
|
I
|
30 |
A
|
F
|
F
|
Y
|
N
|
R
|
S
|
G
|
K
|
H
|
40 |
TM1 | |||||||||
L
|
A
|
T
|
E
|
W
|
N
|
T
|
V
|
S
|
K
|
50 |
L
|
V
|
M
|
G
|
L
|
G
|
I
|
T
|
V
|
C
|
60 |
I
|
F
|
I
|
M
|
L
|
A
|
N
|
L
|
L
|
V
|
70 |
M
|
V
|
A
|
I
|
Y
|
V
|
N
|
R
|
R
|
F
|
80 |
ICL1 | TM2 | ||||||||
H
|
F
|
P
|
I
|
Y
|
Y
|
L
|
M
|
A
|
N
|
90 |
L
|
A
|
A
|
A
|
D
|
F
|
F
|
A
|
G
|
L
|
100 |
A
|
Y
|
F
|
Y
|
L
|
M
|
F
|
N
|
T
|
G
|
110 |
ECL1 | TM3 | ||||||||
P
|
N
|
T
|
R
|
R
|
L
|
T
|
V
|
S
|
T
|
120 |
W
|
L
|
L
|
R
|
Q
|
G
|
L
|
I
|
D
|
T
|
130 |
S
|
L
|
T
|
A
|
S
|
V
|
A
|
N
|
L
|
L
|
140 |
A
|
I
|
A
|
I
|
E
|
R
|
H
|
I
|
T
|
V
|
150 |
ICL2 | |||||||||
F
|
R
|
M
|
Q
|
L
|
H
|
T
|
R
|
M
|
S
|
160 |
TM4 | |||||||||
N
|
R
|
R
|
V
|
V
|
V
|
V
|
I
|
V
|
V
|
170 |
I
|
W
|
T
|
M
|
A
|
I
|
V
|
M
|
G
|
A
|
180 |
ECL2 | |||||||||
I
|
P
|
S
|
V
|
G
|
W
|
N
|
C
|
I
|
C
|
190 |
D
|
I
|
E
|
N
|
C
|
S
|
N
|
M
|
A
|
P
|
200 |
TM5 | |||||||||
L
|
Y
|
S
|
D
|
S
|
Y
|
L
|
V
|
F
|
W
|
210 |
A
|
I
|
F
|
N
|
L
|
V
|
T
|
F
|
V
|
V
|
220 |
M
|
V
|
V
|
L
|
Y
|
A
|
H
|
I
|
F
|
G
|
230 |
|
||
Y
|
V
|
|
|
|
|
|
|
|
|
|
|
|
|
BRIL (b562R | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
TM6 | |||||||
R
|
N
|
R
|
D
|
T
|
M
|
M
|
S
|
255 |
L
|
L
|
K
|
T
|
V
|
V
|
I
|
V
|
L
|
G
|
265 |
A
|
F
|
I
|
I
|
C
|
W
|
T
|
P
|
G
|
L
|
275 |
V
|
L
|
L
|
L
|
L
|
D
|
V
|
C
|
C
|
P
|
285 |
ECL3 | TM7 | ||||||||
Q
|
C
|
D
|
V
|
L
|
A
|
Y
|
E
|
K
|
F
|
295 |
F
|
L
|
L
|
L
|
A
|
E
|
F
|
N
|
S
|
A
|
305 |
M
|
N
|
P
|
I
|
I
|
Y
|
S
|
Y
|
R
|
D
|
315 |
H8 | |||||||||
K
|
E
|
M
|
S
|
A
|
T
|
F
|
R
|
Q
|
I
|
325 |
|
|
L
|
|
|
|
|
|
|
|
|
|
|
|
|
PreScission | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
His(10) | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FLAG | |||||||||
|
|
|
|
|
|
|
|
|
|
SCHEMATIC
Perspective:
Wild-type
Construct
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DIAGRAMS
MUTATIONS
Position | Wild-type | Mutated |
---|
DELETIONS
MODIFICATIONS
AUXILIARY PROTEINS
Protein_type: signal
Name: hemagglutinin
Sequence: None
Deletions:
Positions: N-term_0 None:None
Presence in Crystal:YES
Remarks: None
Protein_type: fusion
Name: BRIL (b562RIL)
Sequence: None
Deletions:
Positions: Within Receptor_1 233:247
Presence in Crystal:YES
Remarks: None
Protein_type: prot_cleavage
Name: PreScission site
Sequence: None
Deletions:
Positions: C-term_2 None:None
Presence in Crystal:YES
Remarks: None
Protein_type: tag
Name: His(10)
Sequence: None
Deletions:
Positions: C-term_3 None:None
Presence in Crystal:YES
Remarks: None
Protein_type: tag
Name: FLAG
Sequence: None
Deletions:
Positions: C-term_4 None:None
Presence in Crystal:YES
Remarks: None
EXPRESSION
Expression method | Host cell type | Host cell | Remarks |
---|---|---|---|
Baculovirus | Sf9 | Insect |
SOLUBILIZATION
Solvent type | Item | Concentration |
---|---|---|
detergent | DDM | 1 %w/v |
additive | CHS | 0.1 %w/v |
Remarks:
PURIFICATION
Purification type | Description |
---|---|
Alkylation by Iodoacetamide | None |
Remarks:None
CRYSTALLIZATION
METHOD: in meso/LCP
TYPE: lipidic cubic phase (LCP) (monoolein (9.9 MAG))
PROTEIN CONCENTRATION: 1-50 mg/ml
Temperature: 20°C
ph : 5.5-5.5
Remarks: Optimalcrystal size of (~200 μm x 20 μm x 5 μm) was achieved over a period of 30 daysThe protein-LCP mixture contained 40% (w/w) protein solution, 54% (w/w) monoolein(Sigma) and 6% (w/w) cholesterol
Chemical lists
Type | Item | Concentration |
---|---|---|
Additional | ||
unknown | Sodium citrate | 0.1 M |
unknown | PEG400 | 34-38 %v/v |
unknown | Ammonium acetate | 200 mM |
Detergent | ||
detergent | DDM | 0.05 % w/v |
Lipid | ||
lipid | CHS | 0.01 %w/v |